Transcription of Reference ID: 3860969
{{id}} {{{paragraph}}}
Example: marketing
Reference ID: 3860969
HIGHLIGHTS OF PRESCRIBING INFORMATION Marked Bradycardia: Cases of marked bradycardia, some of which These highlights do not include all the information needed to use have resulted in cardiac arrest, have been observed within minutes BRIDION safely and effectively. See full prescribing information after administration. Monitor for hemodynamic changes and for BRIDION. administer anticholinergic agents such as atropine if clinically significant bradycardia is observed. ( ). BRIDION (sugammadex) Injection, for intravenous use Respiratory Function Monitoring: Ventilatory support is mandatory Initial Approval: 2015 for patients until adequate spontaneous respiration is restored and the ability to maintain a patent airway is assured. Should ----------------------------INDICATIONS AND USAGE ---------------------------- neuromuscular blockade persist after BRIDION or recur following BRIDION is indicated for the reversal of neuromuscular blockade extubation, take appropriate steps to provide adequate ventilation.
agents (NMBA) and neuromuscular block reversal agents. Doses and timing of BRIDION administration should be based on monitoring for twitch responses and the extent of spontaneous recovery that has occurred. Administer BRIDION intravenously as a single bolus injection. The bolus injection may be given over 10 seconds, into an existing ...
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: